Analystreport

Dermira (NASDAQ: DERM) was given a new $20.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock.

Journey Medical Corporation  (DERM) 
Last journey medical corporation earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.dermira.com